ANXA1 and lung carcinoma: MDX-124, a humanized anti-ANXA1 monoclonal antibody, has been shown to suppress cell proliferation significantly in ANXA1-expressing breast, ovarian, pancreatic, colon, and lung cancer cell lines (p < 0.013).